Latest market price
452.29
+8.44+1.90%
ISRGQT51Intuitive Surgical, Inc.·NASDAQ
452.29+1.90%
News
Up 1.9% — Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story (marketbeat.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
IndexS&P 500, NDXP/E54.30EPS (ttm)8.33Insider Own0.48%Shs Outstand353.28MPerf Week6.00%
Market Cap159.78BForward P/E36.52EPS next Y12.39Insider Trans-1.14%Shs Float350.80MPerf Month13.21%
Enterprise Value154.15BPEG4.10EPS next Q-Inst Own86.89%Short Float2.11%Perf Quarter26.75%
Income2.96BP/S13.80EPS this Y29.05%Inst Trans0.00%Short Ratio2.47Perf Half Y-6.21%
Sales11.58BP/B8.91EPS next Y10.58%ROA15.28%Short Interest7.41MPerf YTD-20.14%
Book/sh50.79P/C26.92EPS next 5Y12.56%ROE17.03%52W High603.86 -25.10%Perf Year-14.18%
Cash/sh16.80P/FCF44.41EPS past 3/5Y29.19% 21.77%ROIC16.04%52W Low328.58 37.65%Perf 3Y64.16%
Dividend Est.-EV/EBITDA36.79Sales past 3/5Y17.39% 18.22%Gross Margin67.19%Volatility3.80% 2.98%Perf 5Y36.44%
Dividend TTM-EV/Sales13.31EPS Y/Y TTM29.75%Oper. Margin28.36%ATR (14)13.22Perf 10Y470.57%
Dividend Ex-Date-Quick Ratio2.49Sales Y/Y TTM38.63%Profit Margin25.54%RSI (14)70.84Recom2.39
Dividend Gr. 3/5Y-Current Ratio3.33EPS Q/Q25.00%SMA207.54%Beta1.43Target Price485.44
Payout0.00%Debt/Eq0.02Sales Q/Q21.72%SMA5014.20%Rel Volume1.21Prev Close443.85
Employees17,021LT Debt/Eq0.01EarningsJan 28SMA2003.69%Avg Volume2.47MPrice452.29
IPO DateJun 16, 2000Option/ShortYes / YesEPS/Sales Surpr.13.37% 4.88%Net Debt/EBITDA-0.71Volume2,997,750Change1.90%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-21-26ReiteratedOppenheimerOutperform$500
Oct-21-26ReiteratedRobert W. Baird$513 → $550
Oct-21-26ReiteratedRaymond JamesOutperform$483 → $480
Oct-21-26ReiteratedLeerink PartnersOutperform$454 → $503
Oct-21-26ReiteratedWells FargoOverweight$487 → $486
Oct-21-26ReiteratedBarclaysOverweight$485 → $500
Oct-21-26ReiteratedRBC CapitalOutperform$600 → $550
Oct-13-26ReiteratedMizuho SecuritiesNeutral$400 → $415
Oct-12-26ReiteratedBTIGBuy$469 → $454
Oct-06-26InitiatedBarclaysOverweight$651 → $485
Latest News· Times ET
Oct-23-26
Oct-22-26
Oct-21-26
Company

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Ownership
Total institutional ownership86.89%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue11,57810,0658,352——————
Cost of Goods Sold Incl. D&A3,7983,4222,718——————
Gross Profit7,7796,6425,634——————
Selling, General and Administrative Excl. Other3,0012,3852,140——————
Research and Development1,4941,3121,145——————
Other Operating Expense
100——————
Operating Income3,2842,9462,349——————
Interest Expense
000——————
Unusual Expense
—————————
Non-Operating Income (Expense)335366325——————
Net Income Before Taxes3,6193,3112,674——————
Income Taxes645435336——————
Consolidated Net Income2,9582,8562,323——————
Net Income From Continuing Operations2,9732,8772,338——————
Net Income2,9582,8562,323——————
EPS (Recurring)8.378.006.54——————
EPS (Basic, Before Extraordinaries)8.378.006.54——————
EPS (Diluted)8.337.876.42——————
EBITDA4,1903,9893,136——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio54.3071.9681.30——————
Price To Sales Ratio13.6320.0922.19——————
Gross Margin67.1965.9967.46——————
Operating Margin28.3629.2728.13——————
Net Margin25.5528.3827.81——————
Shares Outstanding349357355——————
Market Capitalization157,849202,191185,296——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$631.97$547.20$462.44$377.67$292.90● Close Price0.00M8.19M16.37M24.56M32.74MUSD Trades VolumeOctNovDec2026FebMarAprMayJunJulAugSepOct
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
WADORS PATRICIA LSVP Chief Human Resources OffiOct 10 '26Option Exercise0.002,14002,140Oct 13
LOEB GARYEVP & Chief Legal and ComplianOct 10 '26Option Exercise0.002,61207,932Oct 13
Widman FredrikVP Corporate ControllerSep 15 '26Option Exercise94.521,089102,9331,572Sep 16
Widman FredrikVP Corporate ControllerSep 15 '26Sale374.44543203,3211,026Sep 16
Brosius MarkEVP & Chief Mfg and Supply ChaSep 11 '26Sale365.79259,145764Sep 11
Brosius MarkEVP & Chief Mfg and Supply ChaSep 10 '26Sale347.66237,996789Sep 11
Brosius MarkEVP & Chief Mfg and Supply ChaSep 09 '26Sale350.20238,055812Sep 09
Brosius MarkEVP & Chief Mfg and Supply ChaSep 08 '26Sale361.234616,617835Sep 09
Brosius MarkEVP & Chief Mfg and Supply ChaAug 21 '26Sale375.577728,919881Aug 21
Brosius MarkEVP & Chief Mfg and Supply ChaAug 20 '26Sale396.377730,520958Aug 21
Brosius MarkEVP & Chief Mfg and Supply ChaAug 19 '26Sale394.267730,3581,035Aug 19
Brosius MarkEVP & Chief Mfg and Supply ChaAug 18 '26Sale394.007730,3381,112Aug 19
Brosius MarkEVP & Chief Mfg and Supply ChaAug 17 '26Sale390.677730,0821,189Aug 19
GUTHART GARY SDirectorAug 11 '26Sale400.0010,0004,000,0001,245,679Aug 12
Ladd Amy LDirectorAug 11 '26Sale393.107228,303179Aug 11
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.